Apr 19 |
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
|
Apr 11 |
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
|
Apr 8 |
CorMedix enters into 5-year agreement with ARC Dialysis
|
Apr 8 |
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
|
Apr 2 |
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)
|
Mar 12 |
CorMedix (CRMD) Q4 2023 Earnings Call Transcript
|
Mar 12 |
Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCath
|
Mar 12 |
CorMedix GAAP EPS of -$0.26 misses by $0.06
|
Mar 12 |
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Mar 11 |
CorMedix Q4 2023 Earnings Preview
|